Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GENe EXpression in Tissues From Operating Field After Regional or General ANesthesia in Patients Undergoing Breast Cancer Surgery. The GENEXAN Randomized Controlled Genomic Trial

NCT03779685 is registered in ClinicalTrials.gov with Azienda Ospedaliera San Gerardo di Monza as lead sponsor.

NCT NCT03779685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03779685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GENe EXpression in Tissues From Operating Field After Regional or General ANesthesia in Patients Undergoing Breast Cancer Surgery. The GENEXAN Randomized Controlled Genomic Trial
Lead sponsor
Azienda Ospedaliera San Gerardo di Monza
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2021
Completion date
March 1, 2022
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female